| Literature DB >> 32949493 |
Xiang-Ru Shannon Xu1, Emily A Bulger2, Valentino M Gantz1, Carissa Klanseck1, Stephanie R Heimler1, Ankush Auradkar1, Jared B Bennett3, Lauren Ashley Miller1, Sarah Leahy4, Sara Sanz Juste1, Anna Buchman1, Omar S Akbari1, John M Marshall5, Ethan Bier6.
Abstract
CRISPR-Cas9-based gene drive systems possess the inherent capacity to spread progressively throughout target populations. Here we describe two self-copying (or active) guide RNA-only genetic elements, called e-CHACRs and ERACRs. These elements use Cas9 produced in trans by a gene drive either to inactivate the cas9 transgene (e-CHACRs) or to delete and replace the gene drive (ERACRs). e-CHACRs can be inserted at various genomic locations and carry two or more gRNAs, the first copying the e-CHACR and the second mutating and inactivating the cas9 transgene. Alternatively, ERACRs are inserted at the same genomic location as a gene drive, carrying two gRNAs that cut on either side of the gene drive to excise it. e-CHACRs efficiently inactivate Cas9 and can drive to completion in cage experiments. Similarly, ERACRs, particularly those carrying a recoded cDNA-restoring endogenous gene activity, can drive reliably to fully replace a gene drive. We compare the strengths of these two systems.Keywords: CRISPR; Drosophila; ERACR; MCR; active genetics; drive-neutralizing; e-CHACR; gene drive; modeling; risk management
Mesh:
Substances:
Year: 2020 PMID: 32949493 DOI: 10.1016/j.molcel.2020.09.003
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970